European Urology Oncology
Издатель: Elsevier · ISSN 2588-9311 · 93 статей
- Reply to Cameron E. Alexander, Ashwin Sachdeva, and Noel W. Clarke’s Letter to Editor Re: Develtere D, Devos G. Metformin in prostate cancer: A negative repurposing story across the disease continuum. Urol Oncol 2026. https://doi.org/10.1016/j.euo.2026.04.014.
- Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. 2026;9:743–745. http://dx.doi.org/10.1016/j.euo.2026.04.008
- Reply to Kelly M. de Ligt, Sarah P. Psutka, and Laura S. Mertens’s Letter to the Editor Re: Martino Pedrani, Alberto De Giorgi, Andrea Gallina, et al. When Patients Refuse Radical Cystectomy: Integrating Trimodality Therapy in the Perioperative ICI/ADC Era. Eur Urol Oncol. 2026;9:743–745. http://dx.doi.org/10.1016/j.euo.2026.04.008
- Re: Roberto Contieri, Marco Paciotti, Alessandro Uleri, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non–muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe Trial. Eur Urol Oncol 2026;9:404–12: Pathological Restaging and Omission of Second TURBT in T1 NMIBC
- Reply to Yue Chang’s Letter to the Editor re: Contieri R, Paciotti M, Uleri A, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non–muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe trial. Eur Urol Oncol 2026;9:404–12
- Individualized Oncologic Surveillance After Radical Prostatectomy for Localized Prostate Cancer
- Adjuvant Pembrolizumab in Clear Cell Renal Cell Carcinoma: Eligibility Is Only the Beginning
- Rethinking the 3-cm Rule: Toward Biology-guided Management of Sporadic Bilateral Multifocal Papillary Renal Cell Carcinoma
- Natural History After Likely Cure Versus Recurrence After Prostate Radiotherapy (RAPTOR)
- Editorial Board
- Contents
- Hall of Fame
- The Price of Cure: Rethinking Success in High-risk Prostate Cancer
- Patient Selection Matters: Who Is Represented in PROTEUS?
- Introducing Key Performance Metrics for Assessing the Benefits and Harm of the Prostate Cancer Diagnostic Pathways
- Pembrolizumab Plus Lenvatinib in Participants with Docetaxel-pretreated Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort E
- Evaluating the Surrogacy of Pathological Complete Response at Radical Cystectomy in Neoadjuvant-based Muscle-invasive Bladder Cancer Trials
- Efficacy of Olaparib Plus Abiraterone for Patients with Metastatic Castration-resistant Prostate Cancer and Single Homologous Recombination Repair Gene Mutations in PROpel
- Feasibility and Characterization of Immune-related Pathologic Response Criteria in Renal Cell Carcinoma
- Multiregional Immune Profiling Reveals Prognostic Patterns in Bladder Cancer
- Diagnostic Value of Fluorine-18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Staging Histological Subtypes of Invasive Bladder Cancer
- Integrating Genomic Prostate Score with Preoperative and Postoperative Cancer of the Prostate Risk Assessment Scores to Predict Biochemical Recurrence after Radical Prostatectomy
- Salvage High-intensity Focused Ultrasound for Prostate Cancer Recurrence after Radiotherapy (HIFI-2 Study)
- MRI Quality and Reader Experience in Organized Prostate Cancer Screening: Insights from the PROBASE Trial
- Head-to-head Comparison of Multimodal Imaging for Prostate Cancer Detection and Local Staging with Whole-mount Histopathology Reference
- Concomitant MRI-detected and MRI-undetected Prostate Cancer with Implications for Biopsy Strategies and Focal Therapy Planning: An Analysis of the PROMIS and PICTURE Trials
- Quality of Life After Postprostatectomy Radiotherapy: A TROG 08.03 RAVES Randomized Controlled Trial Substudy
- Long-term Oncological Outcomes of Retzius-sparing Versus Anterior Robot-assisted Radical Prostatectomy: Post Hoc Analysis of a Randomized Cohort
- Real-World Multicentre Evaluation of GALEAS Bladder for Detecting Bladder Cancer in UK NHS Haematuria Clinics
- Natural History, Tumor Growth Kinetics, and Renal Functional Outcomes of Sporadic Bilateral Multifocal Papillary Renal Cell Carcinoma: A 25-yr Prospective Cohort Study